Price-negotiation provisions that are out of step with reality are discouraging funders and Big Pharma partners from ...

Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent ...

The World Health Organization names antimicrobial resistance as one of the most urgent public health threats, but it remains ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and ...

Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making ...

Around 300 FDA staffers laid off last week are being asked to return. So far, the Trump administration has terminated some ...